Ohr Pharmaceutical is a pharmaceutical company focused on the clinical development of new drugs to address underserved therapeutic needs in markets that are large and growing. The company is currently focused on two lead compounds: Squalamine Eye Drops for treating … Continue reading →

Intercept Pharmaceuticals is a clinical-stage biopharmaceutical company utilizing its expertise in bile acid chemistry to develop and commercialize novel therapeutics for the treatment of orphan and more prevalent liver diseases. OCA (obeticholic acid), the company’s lead product candidate, is initially … Continue reading →

Tranzyme Pharma is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-based therapeutics to treat upper gastrointestinal motility disorders. Though more than 40 percent of people in the U.S. are affected by these recurring conditions, only … Continue reading →

Venaxis is an in vitro diagnostic company pursuing clinical development and commercialization of APPY1, its blood-based appendicitis test. Designed to aid in identifying patients at low risk for acute appendicitis, thus enabling more conservative patient management, APPY1 is being initially … Continue reading →

Anthera Pharmaceuticals is a biopharmaceutical company engaged in developing and commercializing products for the treatment of serious illnesses, such as cardiovascular and autoimmune diseases. The company’s clinical-stage program includes a Phase 2 study of blisibimod, which targets elevated B-lymphocyte stimulator … Continue reading →

RXi Pharmaceuticals is a biotechnology company engaged in the discovery, development and commercialization of innovative therapies to address major unmet medical needs using RNA-targeted technologies. Building on the groundbreaking work of Nobel Laureate and RXi Scientific Advisory Board member Dr. … Continue reading →

Catalyst Pharmaceutical Partners is a development-stage specialty pharmaceutical company engaged in developing and commercializing prescription drugs that target orphan drug diseases as well as disorders of the central nervous system. The company currently has three products in development: Firdapse, planned … Continue reading →

TG Therapeutics is a clinical-stage biopharmaceutical company engaged in acquiring, developing and commercializing pharmaceutical products that are medically important for the treatment of cancer and other underserved therapeutic needs. The company is currently developing two advanced therapies to target hematological … Continue reading →

Navidea Biopharmaceuticals is a biopharmaceutical company engaged in developing and commercializing precision diagnostics and radiopharmaceutical agents. The company is actively developing four radiopharmaceutical agent platforms: Lymphoseek, NAV4694, NAV5001 and RIGScan. The company aims to deliver superior growth and shareholder return … Continue reading →

Eternity Healthcare is a leading medical technology company in the United States. The company’s state-of-the-art medical devices include diagnostic kits, digital cholesterol readers, injection-free needles and many others. The company’s products are sold throughout the world to consumers and to … Continue reading →